Stocks sell off - what I am looking at
Stocks sell off, with an update on SMC and other ideas.
Stocks sell off, with an update on SMC and other ideas.
Intuit’s $3.68 billion Mailchimp sale removes a noncore unit as TurboTax shifts to assisted filing and Credit Karma faces volume pressure.
Netflix’s WWE deal pairs 52 weeks of programming with its ad-supported tier, while Peter Rice takes over content amid layoffs and Bela…
Sabre’s $4.6 billion debt load and 2029-30 maturities frame Constellation Software’s 12.7% PEMS stake, despite management’s 9% annual…
Qualcomm’s Q4 FY2026 review assesses its semiconductor business, moat, financials and valuation amid a chip-sector rebound.
Intuit shares fell 9.8% after chatbots slowed Credit Karma, while QuickBooks grew mid-teens and FY27 guidance stayed unchanged.
Bloom Energy's revenue rose 138% year over year as data center moratoriums pressured its shares.
Ford trades 35% below its May 2026 high as investors treat Model e's roughly $4 billion annual loss as permanent despite higher EBIT…
Nu Holdings is expanding banking in Brazil, Mexico, Colombia and the US while investors scrutinize Brazilian credit quality and lending…
Strategy, BitMine, Sharplink and Hyperliquid Strategies traded at 14% to 33% discounts to token NAV on November 18, 2026, testing buy-wide,…
ABG · long Asbury Automotive Group's changed setup and underperformance versus other public dealers form the basis for a renewed long thesis.
PINFRA's nonvoting PINFRAL shares trade 27.2% below voting stock despite identical economics, while its toll-road concessions average 31…
Booking Holdings trades at 19x earnings, its lowest since 2022, after a 20% annual decline, with the thesis resting on durable online…
Oak Bloke’s 2026 picks have returned 37% in GBP, with AltynGold, Geiger Counter, Silvercorp and China-focused trusts still rated buys…
Crocs’ core brand surpassed $1 billion in quarterly revenue, while HEYDUDE weakness, tariffs and 2025 impairments weigh on shares trading…
Adobe’s RPO and ARR growth continue to decelerate, while Oracle’s AI cloud capex economics face a supply-normalization test.
AstraZeneca's tozorakimab cut COPD attacks 29% to 34% in two Phase III trials, including 23% among low-eosinophil patients after Wainua's…
Ten-year Treasury yields breach 4.9% as Steve Eisman discusses AI fears, OpenAI's price cut, Oracle's 30% revenue growth and Tesla's…
Lululemon’s North American sales, margins and legging demand are falling as Alo and Vuori gain share, leaving its brand moat and depressed…
Chevron’s 2027 EPS could be underestimated by about $4.50 per share if U.S.-Iran conflict keeps oil near $100 rather than forecast $74 to…
Every publication on this site, hand-picked.
Every account on this site, hand-picked.
Ordered by how often our editor reaches for them.